BRC Group Holdings, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data BRC Group Holdings, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2020	FY2022	FY2023	FY2024	FY2025
Revenue	190	322	423	652	834	1,555	939	1,466	986	968
Cost of revenue	14.8	0.4	0.8	7.58		27	60.8	173	168	145
Gross profit	176	322	422	645		1,528	879	1,293	818	822
Selling, general and administrative	82.1	228	311	385	429	906	655	765	689	600
Operating expenses	142	293	378	485	558	1,040
Operating income	48.7	28.8	45.4	167	276	515	29.9	96.1	-498	75.6
Interest expense	2	8.38	33.4	50.2	65.2	92.5	141	156	133	92.7
Interest income	0.32	0.42	1.33	1.58	0.56	0.23	2.74	3.88	3.6	3.71
Pre-tax income	47	20.4	21.3	117	279	615	-334	-199	-900	230
Income tax	14.3	8.51	4.9	34.6	75.4	164	-65.3	-39.1	22	-9.89
Income from continuing operations							-269	-160	-922	239
Net income to minority interests	11.2	0.38	0.89	0.34	-1.13	5.75	3.24	-5.72	-10.7	2.87
Net income	21.5	11.6	16.3	81.6	205	445	-160	-99.9	-764	307
EBITDA	53	40	59.2	186	296	540	69.8	146	-452	111
EPS, basic	1.19	0.50	0.60	3.08	7.83	15.99	-5.95	-3.69	-25.46	9.80
EPS, diluted	1.17	0.48	0.58	2.95	7.56	15.09	-5.95	-3.69	-25.46	9.80
Shares, basic (weighted)	18.1	23.2	25.9	26.4	25.6	27.4	28.2	29.3	30.3	30.6
Shares, diluted (weighted)	18.4	24.3	26.8	27.5	26.5	29	28.2	29.3	30.3	30.6
Dividend per share	0.28	0.67	0.74	1.49	1.33	12.50	4.00	4.00	1.00

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2020	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	115	133	179	104	104	279	269	223	147	227
Receivables	19	20	42.1	46.6	40.8	49.7	149	82	68.7	55.5
Inventory						3.98	102	93.7	63	48
Other current assets	5.74	22.6	79.5	81.8	93.2	464	461	242	157	129
Total current assets	158
Property, plant and equipment	5.79	12	15.5	12.7	11.7	12.9	27.1	25.2	18.7	17.6
Lease right-of-use assets				1.03	48.8	57	88.6	87.2	51.5	32.1
Goodwill	48.9	98.8	223	224	227	251	507	437	393	393
Intangible assets	41.2	56.9	91.4	221	191	208	374	198	146	118
Other non-current assets	2.16
Total assets	265	1,387	1,958	2,318	2,663	5,852	6,111	6,081	1,783	1,707
Accounts payable	2.7	2.65	5.65	4.48	2.72	6.33	81.4	44	51.2	41.5
Accrued liabilities	15.7				28.2	96.3	68.2	55.8	51.7
Deferred revenue	4.13	3.14	69.1
Total current liabilities	83.7
Long-term debt	27.7	204	460	688	871	1,607	1,722	1,668	1,531	1,302
Other non-current liabilities	2.86				28.4	51.2
Total liabilities	114	1,121	1,699	1,928	2,124	4,802	5,427	5,721	2,239	1,827
Total debt									1,531	1,428
Paid-in capital	141	260	259	323	310	413	494	572	589	598
Retained earnings	9.89	6.58	1.58	39.5	203	249	-45.2	-281	-1,071	-763
Other comprehensive income	-1.71	-0.53	-2.16	-1.99	-0.82	-1.08	-2.47	0.23	-6.57	-6.27
Shareholders' equity	149	266	258	361	513	661	447	291	-488	-172
Minority interests	1.05	-0.18	0.6	29.6	26.4	43.9	59.4	68.4	32.2	51.3
Total equity	150	266	259	390	539	705	506	360	-456	-120
Total liabilities and equity	265	1,387	1,958	2,318	2,663	5,852	6,111	6,081	1,783	1,707
Shares outstanding	19.1	26.6	26.6	27	25.8	27.6	28.5	29.9	30.5	30.6

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2020	FY2022	FY2023	FY2024	FY2025
Net income	32.7	11.9	16.4	81.9	204	451	-157	-106	-775	310
Depreciation and amortization	4.31	11.1	13.8	19	19.4	25.9	40	49.6	45.4	35.2
Stock-based compensation	2.77	10.3	13	15.9	18.6	36	61.1	45.1	19.1	14
Deferred income tax	3.55	5.73	1.99	10.9	61.6	61.8	-80.4	-40.9	25.9	11.5
Change in receivables		1.61	-12.9	-37.6	18.8	-0.72	6.6	26.4	2.23	6.79
Change in inventory									-7.42
Change in payables	23.3	-30.4	3.56	32.6	31.3	37.8	-141	-79.8	-14.1	-24.6
Cash from operations	80.3	-81.8	-102	-27.2	57.7	50.9	6.65	24.5	264	-59.7
Capital expenditures	-0.73	-0.83	-5.43	-3.46
Acquisitions	-126	-4.26	-53.9	-2.16			-262	-26.2	-19.1	0
Sales and maturities of investments				18.2
Cash from investing	-34.1	-17.8	-154	-438	21.8	-957	-32.3	301	441	311
Debt issued	27.7	179	259	282	187	1,249	51.6	0.19	0
Debt repaid						-2.8
Stock issued	22.8			0.06	0	64.7	0	115	1.01	0
Share buybacks			-18.7	-4.27	-48.2	-2.66	-6.52	-69.5	0
Dividends paid	-5.33	-16.8	-22.7	-41.1	-38.8	-347	-119	-141	-33.7	0
Cash from financing	40.4	134	285	389	-80.7	1,081	17.6	-366	-672	-279
Exchange rate effect	-1.29	2.67	-0.86	0.07	1.31	-0.38	-0.93	3.16	-9.3	0.2
Net change in cash	85.3	37.1	27.7	-75.5	0.1	175	-8.93	-37.1	22.8	-27.4
Free cash flow	79.6	-82.6	-108	-30.7
Interest paid	0.38	18.8	50.1	75.6	98.6	138	193	315	240	97
Income taxes paid	-0.69	-15	6.5	8.65	2.37	88.2	49.4	20.1	6.92	5.23

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $25.25 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	87.9%	Gross profit / revenue.
Operating margin	27.9%	Operating income / revenue.
EBITDA margin	30.7%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	39.1%	Pre-tax income / revenue.
Net margin	36.2%	Net income / revenue.
Operating cash flow margin	-1.3%	Cash from operations / revenue.
Effective tax rate	2.9%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	289.6%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	20.9%	Net income / average total assets.
SG&A / revenue	49.1%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	1.0%	Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue	2.8%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-1.9%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	1.0%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	3.0%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	0.5%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-2.2%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 3y	36.3%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	-22.8%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA CAGR, 3y	16.6%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	-17.8%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income CAGR, 5y	8.4%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS CAGR, 5y	5.3%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-122.7%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y	-4.3%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-34.6%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-8.5%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.7%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	2.7%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	2.9%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Liabilities / assets	89.8%	Total liabilities / total assets.
Interest coverage	4.14x	Operating income / interest expense.
Goodwill and intangibles / assets	25.1%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$352.4M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.58x	Revenue / average total assets.
Fixed asset turnover	63.7x	Revenue / average property, plant and equipment.
Inventory turnover	2.91x	Cost of revenue / average inventory.
Days inventory	126 days	365 x average inventory / cost of revenue.
Receivables turnover	18.5x	Revenue / average receivables.
Days sales outstanding	20 days	365 x average receivables / revenue.
Days payables	94 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	51 days	Days inventory + days sales outstanding - days payables.

Per share

Metric	Value	How it is calculated
EPS, diluted	$10.72	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$29.57	Revenue / diluted weighted shares.
Operating cash flow per share	-$0.38	Cash from operations / diluted weighted shares.
Book value per share	$3.54	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$8.77	Tangible book value / shares outstanding.
Cash per share	$3.83	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$770.1M	Share price x shares outstanding.
Enterprise value	$615.9M	Market cap + total debt - cash - short-term investments.
P/E	1.87x	Market cap / net income. Only when net income is positive.
P/S	0.68x	Market cap / revenue.
P/B	5.42x	Market cap / shareholders' equity. Only when equity is positive.
EV/Sales	0.54x	Enterprise value / revenue.
EV/EBIT	1.94x	Enterprise value / operating income, when both are positive.
EV/EBITDA	1.77x	Enterprise value / EBITDA, when both are positive.
Earnings yield	53.5%	Net income / market cap (the inverse of P/E).

What was BRC Group Holdings, Inc.'s revenue in fiscal 2025?

BRC Group Holdings, Inc. reported revenue of $967.6M for fiscal 2025, 1.9% lower than the year before.

Was BRC Group Holdings, Inc. profitable in fiscal 2025?

Yes. Net income was $307.4M, a net margin of 31.8%.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to BRC Group Holdings, Inc.